AstraZeneca PLC Files Form 6-K
Ticker: AZN · Form: 6-K · Filed: Aug 26, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | Aug 26, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-issuer, sec-filing
Related Tickers: AZN
TL;DR
AZN filed a 6-K, standard foreign issuer report. Nothing new, just housekeeping.
AI Summary
AstraZeneca PLC filed a Form 6-K on August 26, 2025, reporting its status as a foreign issuer. The filing confirms AstraZeneca PLC's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom, and that it files annual reports under Form 20-F.
Why It Matters
This filing is a routine disclosure for foreign issuers, providing updated contact and reporting information to the SEC, which is important for investors tracking the company's regulatory compliance.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign issuer and does not contain new material financial or operational information.
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the Form 6-K
- 001-11960 (company) — SEC File Number for AstraZeneca PLC
- 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom (company) — Principal executive offices address
- Form 20-F (company) — Annual report form filed by the registrant
- August 2025 (date) — Reporting period for the Form 6-K
- 20250826 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer submitted to the SEC pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, typically used to provide information that the company makes public in its home country or files with a stock exchange.
What is AstraZeneca PLC's SEC file number?
AstraZeneca PLC's SEC file number is 001-11960.
Where are AstraZeneca PLC's principal executive offices located?
AstraZeneca PLC's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom.
Does AstraZeneca PLC file annual reports under Form 20-F or Form 40-F?
AstraZeneca PLC indicates that it files annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed on August 26, 2025.
Filing Stats: 1,134 words · 5 min read · ~4 pages · Grade level 9.8 · Accepted 2025-08-26 13:22:13
Filing Documents
- a6775w.htm (6-K) — 75KB
- 0001654954-25-010040.txt ( ) — 76KB
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     AstraZeneca PLC     Date: 26   August 2025     By: /s/ Matthew Bowden   Name: Matthew Bowden   Title: Company Secretary